Investigating the Efficiency of Recombinant FliC-Loaded Bacillus subtilis Spores in Mice Immunization against Salmonella enterica Serovar Typhi

Background: Bacterial spores are among the most efficient vaccine delivery vehicles. Because of their safety and efficacy, Bacillus subtilis spores are increasingly used in this regard. The negatively charged surfaces of the spores allow antigens to be adsorbed onto these structures. In this study, a candidate vaccine against Salmonella enterica serovar Typhi was adsorbed onto B. subtilis spores and the immunogenicity of the formulation was investigated in BALB/c mice. Methods: This work was performed during 2018–2019 in Islamic Azad University of Lahijan. FliC protein was recombinantly expressed in E. coli BL21 (DE3) cells and purified by affinity chromatography. On the other hand, B. subtilis strain PY79 (ATCC1609) was cultured in DSM medium and after the sporulation, FliC protein was adsorbed onto the spores in three different pH values (4, 7 and 10) and the adsorption was verified using dot-blot assay. FliC-adsorbed spores were then administered to BALB/c mice through the subcutaneous route. Mice immunization was evaluated by serum IgG assessment and challenge study. Results: FliC protein was successfully expressed and purified. Sporulation was controlled by phase-contrast microscopy. Serum IgG assay showed significant stimulation of the mice’s humoral immune system. Immunized mice were able to resist bacterial infection. Conclusion: The results showed the efficiency of spores as natural adjuvants for the stimulation of mice immune system. The formulation can be exploited for the delivery of recombinant vaccines against bacterial pathogens.

[1]  S. Nazarian,et al.  Immunogenicity Evaluation of Recombinant Staphylococcus aureus Enterotoxin B (rSEB) and rSEB-loaded Chitosan Nanoparticles Following Nasal Administration. , 2020, Iranian journal of allergy, asthma, and immunology.

[2]  Yongan Zhang,et al.  Oral vaccination of tilapia against Streptococcus agalactiae using Bacillus subtilis spores expressing Sip , 2019, Fish & shellfish immunology.

[3]  A. Arpanaei,et al.  EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7 , 2018, Artificial cells, nanomedicine, and biotechnology.

[4]  Jeongmin Song,et al.  Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design , 2018, Vaccines.

[5]  Karl Pedersen,et al.  Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica , 2018, npj Vaccines.

[6]  K. Pan,et al.  Surface display of OmpC of Salmonella serovar Pullorum on Bacillus subtilis spores , 2018, PloS one.

[7]  Harsh Panwar,et al.  Bacillus As Potential Probiotics: Status, Concerns, and Future Perspectives , 2017, Front. Microbiol..

[8]  J. Crump,et al.  Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study , 2017, The Lancet. Global health.

[9]  A. Arpanaei,et al.  Nanoparticles in Vaccine Development , 2015 .

[10]  S. Bertholet,et al.  Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants , 2014, Proceedings of the National Academy of Sciences.

[11]  D. Rao,et al.  Novel adjuvants & delivery vehicles for vaccines development: A road ahead , 2013, The Indian journal of medical research.

[12]  M. Rostamian,et al.  Expression and purification of neurotoxin-associated protein HA-33/A from Clostridium botulinum and evaluation of its antigenicity. , 2013, Iranian biomedical journal.

[13]  M. Levine,et al.  Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin Glycoconjugates , 2013, PloS one.

[14]  W. B. Luiz,et al.  Bacillus subtilis Endospores at High Purity and Recovery Yields: Optimization of Growth Conditions and Purification Method , 2012, Current Microbiology.

[15]  K. Takehara,et al.  Efficacy of Soluble Recombinant FliC Protein from Salmonella enterica Serovar Enteritidis as a Potential Vaccine Candidate Against Homologous Challenge in Chickens , 2012, Avian diseases.

[16]  Y. K. Choi,et al.  Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine. , 2012, Vaccine.

[17]  U. Stahl,et al.  Spore-forming bacteria and their utilisation as probiotics. , 2012, Beneficial microbes.

[18]  C. Médigue,et al.  Reannotation of the genome sequence of Clostridium difficile strain 630. , 2011, Journal of medical microbiology.

[19]  M. Levine,et al.  Salmonella enterica Serovar Enteritidis Core O Polysaccharide Conjugated to H:g,m Flagellin as a Candidate Vaccine for Protection against Invasive Infection with S. Enteritidis , 2011, Infection and Immunity.

[20]  E. Montomoli,et al.  Current adjuvants and new perspectives in vaccine formulation , 2011, Expert review of vaccines.

[21]  V. Schijns,et al.  Trends in vaccine adjuvants , 2011, Expert review of vaccines.

[22]  S. Cutting,et al.  Mucosal delivery of antigens using adsorption to bacterial spores. , 2010, Vaccine.

[23]  J. Crump,et al.  Global trends in typhoid and paratyphoid Fever. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Fangli Lu,et al.  Immunogenicity of recombinant Bacillus subtilis spores expressing Clonorchis sinensis tegumental protein , 2007, Parasitology Research.

[25]  H. Nguyen,et al.  Evaluation of different promoter sequences and antigen sorting signals on the immunogenicity of Bacillus subtilis vaccine vehicles. , 2007, Vaccine.

[26]  A. Barnes,et al.  Bacillus subtilis spores: A novel microparticle adjuvant which can instruct a balanced Th1 and Th2 immune response to specific antigen , 2007, European journal of immunology.

[27]  W. Schumann,et al.  Stable episomal expression system under control of a stress inducible promoter enhances the immunogenicity of Bacillus subtilis as a vector for antigen delivery. , 2006, Vaccine.

[28]  S. Cutting,et al.  The use of bacterial spore formers as probiotics. , 2005, FEMS microbiology reviews.

[29]  M. Levine,et al.  Vaccine development strategies for improving immunization: the role of modern immunology , 2004, Nature Immunology.

[30]  Emilia M F Mauriello,et al.  Display of heterologous antigens on the Bacillus subtilis spore coat using CotC as a fusion partner. , 2004, Vaccine.

[31]  P. Reeves,et al.  Species-Wide Variation in the Escherichia coli Flagellin (H-Antigen) Gene , 2003, Journal of bacteriology.

[32]  S. Makino,et al.  Salmonella enteritidis FliC (Flagella Filament Protein) Induces Human β-Defensin-2 mRNA Production by Caco-2 Cells* , 2001, The Journal of Biological Chemistry.

[33]  J. Lau,et al.  Vaccines for preventing typhoid fever , 2018, The Cochrane database of systematic reviews.

[34]  D. Zurakowski,et al.  A statistically defined endpoint titer determination method for immunoassays. , 1998, Journal of immunological methods.

[35]  A. Johnson,et al.  Molecular adjuvants and immunomodulators: new approaches to immunization , 1994, Clinical Microbiology Reviews.

[36]  N. Kruger,et al.  The Bradford method for protein quantitation. , 1994, Methods in molecular biology.

[37]  R. Miller,et al.  Preparation and storage of competent Escherichia coli cells. , 1993, Methods in enzymology.

[38]  A. Hoffmann,et al.  Purification of his-tagged proteins in non-denaturing conditions suggests a convenient method for protein interaction studies. , 1991, Nucleic acids research.